Skip to content
Clinical Trials – home
BelgiumBack to Belgium

Clinical trials in Hamme-Mille – page 156

1 947 clinical trials in Hamme-Mille, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.

Hamme-Mille at a glance
1 947
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

1 947 trials in Hamme-Mille

Open in trial search

Study of Chemotherapy With Pembrolizumab and Olaparib for Patients With Advanced Epithelial Ovarian Cancer Without BRCA Mutation

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Anhydrous Docetaxel
  • Sponsor:Merck Sharp & Dohme LLC

Study comparing tarlatamab with topotecan in patients with relapsed small cell lung cancer after first-line chemotherapy

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Amgen Inc.

Cataract

Not recruiting

Study on the Effect and Safety of Phenylephrine Hydrochloride, Tropicamide, and Lidocaine Hydrochloride in Children with Cataracts Undergoing Surgery

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Tropicamide
  • Sponsor:Antwerp University Hospital

Epilepsy

Not recruiting

Study on Ganaxolone for Children and Adults with Epilepsy Related to Tuberous Sclerosis Complex

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Ganaxolone
  • Sponsor:Marinus Pharmaceuticals Inc.

Study on the Effects of Adalimumab and Saline in Patients Undergoing Needle Fasciotomy for Dupuytren's Disease

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Adalimumab
  • Sponsor:UZ Leuven

Ischaemic stroke

Not recruiting

Study on the Safety and Effectiveness of Tenecteplase for Patients with Acute Ischemic Stroke and Incomplete Reperfusion After Mechanical Thrombectomy

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Tenecteplase
  • Sponsor:Insel Gruppe AG

Study on JNJ-81201887 for Treating Geographic Atrophy in Age-related Macular Degeneration Patients

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Onzemipgene parvec
  • Sponsor:Janssen Cilag International

Study on Volixibat for Treating Itching in Patients with Primary Sclerosing Cholangitis

Investigational
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Volixibat
  • Sponsor:Mirum Pharmaceuticals Inc.

Colitis ulcerative

Not recruiting

Study on the Safety and Effectiveness of ABBV-668 for Adults with Moderate to Severe Ulcerative Colitis

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:ABBV-668
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Open angle glaucoma+2

Not recruiting

Study on the Effectiveness of Citicoline Eye Drops for Visual Field Preservation in Patients with Open Angle Glaucoma

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Citicoline Sodium
  • Sponsor:Omikron Italia S.r.l.

Study Comparing Chemotherapy with Nivolumab to Chemotherapy Alone for Patients with Resectable Non-small Cell Lung Cancer

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Malignant melanoma

Not recruiting

Study Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Stage II-IV Melanoma

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Merck Sharp & Dohme LLC

Other cities in Belgium

The busiest research cities in the country

All 164 cities in Belgium

Clinical research in Hamme-Mille

What the registry says about research in the country

01 Viral Infections & Dermatology

Clinical research focusing on recurrent orofacial herpes and non-genital wart treatments, evaluating innovative therapeutic approaches for common viral skin conditions.

  • Herpes Management Study
  • Wart Treatment Evaluation

These trials aim to assess the effectiveness of specialized treatments in reducing infection recurrence and promoting lesion clearance.

02 Treatment Efficacy Studies

Comprehensive evaluation of therapeutic interventions through placebo-controlled trials, focusing on long-term effectiveness and patient outcomes.

  • 12-month Episode Reduction Analysis
  • Comparative Treatment Assessment

Research protocols designed to measure treatment success rates and duration of therapeutic effects.

03 Clinical Research Methodology

Implementation of double-blind randomized studies to ensure unbiased evaluation of treatment efficacy in dermatological conditions.

  • Placebo-Controlled Protocols
  • Treatment Duration Analysis

Structured research approaches examining both pediatric and adult treatment formulations.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.